Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.

Johnson C, Han Y, Hughart N, McCarra J, Alpini G, Meng F.

Transl Gastrointest Cancer. 2012 Apr 1;1(1):58-70.

PMID:
22724089
[PubMed]
Free PMC Article
2.

Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.

Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD.

Gastroenterology. 2013 Sep;145(3):521-36. doi: 10.1053/j.gastro.2013.06.052. Epub 2013 Jul 1. Review.

PMID:
23827861
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.

Ehlken H, Schramm C.

Dig Dis. 2013;31(1):118-25. doi: 10.1159/000347206. Epub 2013 Jun 17. Review.

PMID:
23797133
[PubMed - indexed for MEDLINE]
4.

An update on cholangiocarcinoma associated with primary sclerosing cholangitis.

Fevery J, Verslype C.

Curr Opin Gastroenterol. 2010 May;26(3):236-45. doi: 10.1097/MOG.0b013e328337b311. Review.

PMID:
20216413
[PubMed - indexed for MEDLINE]
5.

Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.

Timmer MR, Beuers U, Fockens P, Ponsioen CY, Rauws EA, Wang KK, Krishnadath KK.

Inflamm Bowel Dis. 2013 Jul;19(8):1789-97. doi: 10.1097/MIB.0b013e318281f49a. Review.

PMID:
23615529
[PubMed - indexed for MEDLINE]
6.

The epidermal growth factor receptor: a link between inflammation and liver cancer.

Berasain C, Perugorria MJ, Latasa MU, Castillo J, Goñi S, Santamaría M, Prieto J, Avila MA.

Exp Biol Med (Maywood). 2009 Jul;234(7):713-25. doi: 10.3181/0901-MR-12. Epub 2009 May 8. Review.

PMID:
19429859
[PubMed - indexed for MEDLINE]
7.

Genes and viruses in hepatobiliary neoplasia.

Reeves ME, DeMatteo RP.

Semin Surg Oncol. 2000 Sep-Oct;19(2):84-93. Review.

PMID:
11126384
[PubMed - indexed for MEDLINE]
8.

NF-κB and STAT3 - key players in liver inflammation and cancer.

He G, Karin M.

Cell Res. 2011 Jan;21(1):159-68. doi: 10.1038/cr.2010.183. Epub 2010 Dec 28. Review.

PMID:
21187858
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Epigenetic alterations in cholangiocarcinoma-sustained IL-6/STAT3 signaling in cholangio- carcinoma due to SOCS3 epigenetic silencing.

Isomoto H.

Digestion. 2009;79 Suppl 1:2-8. doi: 10.1159/000167859. Epub 2009 Jan 20. Review.

PMID:
19153483
[PubMed - indexed for MEDLINE]
10.

Hepatobiliary malignancies: lessons from Asia.

Wong TC, Poon RT.

Dig Dis. 2013;31(1):130-7. doi: 10.1159/000347208. Epub 2013 Jun 17. Review.

PMID:
23797135
[PubMed - indexed for MEDLINE]
11.

Sclerosing cholangitis.

MacFaul GR, Chapman RW.

Curr Opin Gastroenterol. 2005 May;21(3):348-53. Review.

PMID:
15818157
[PubMed - indexed for MEDLINE]
12.

Primary sclerosing cholangitis and cholangiocarcinoma.

Lazaridis KN, Gores GJ.

Semin Liver Dis. 2006 Feb;26(1):42-51. Review.

PMID:
16496232
[PubMed - indexed for MEDLINE]
13.

PSC, AIH and overlap syndrome in inflammatory bowel disease.

Trivedi PJ, Chapman RW.

Clin Res Hepatol Gastroenterol. 2012 Oct;36(5):420-36. doi: 10.1016/j.clinre.2011.10.007. Epub 2012 Feb 3. Review.

PMID:
22306055
[PubMed - indexed for MEDLINE]
14.

Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.

Maggiore G, Riva S, Sciveres M.

Minerva Gastroenterol Dietol. 2009 Mar;55(1):53-70. Review.

PMID:
19212308
[PubMed - indexed for MEDLINE]
15.

Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.

van Milligen de Wit AW, van Deventer SJ, Tytgat GN.

Am J Gastroenterol. 1995 Jun;90(6):893-900. Review.

PMID:
7771416
[PubMed - indexed for MEDLINE]
16.

Hepatobiliary malignancy.

Jones BA, Gores GJ.

Clin Liver Dis. 1998 May;2(2):437-49, xi-xii. Review.

PMID:
15560042
[PubMed - indexed for MEDLINE]
17.

Cholangiocarcinoma in primary sclerosing cholangitis.

Abbas G, Lindor KD.

J Gastrointest Cancer. 2009;40(1-2):19-25. doi: 10.1007/s12029-009-9085-8. Epub 2009 Aug 25. Review.

PMID:
19705300
[PubMed - indexed for MEDLINE]
18.

Epigenetic alterations associated with cholangiocarcinoma (review).

Isomoto H.

Oncol Rep. 2009 Aug;22(2):227-32. Review.

PMID:
19578760
[PubMed - indexed for MEDLINE]
19.

Molecular mechanism of liver cancer.

Pan H, Fu X, Huang W.

Anticancer Agents Med Chem. 2011 Jul;11(6):493-9. Review.

PMID:
21554201
[PubMed - indexed for MEDLINE]
20.

Recent insights in primary sclerosing cholangitis.

Ponsioen CY.

J Dig Dis. 2012 Jul;13(7):337-41. doi: 10.1111/j.1751-2980.2012.00605.x. Review.

PMID:
22713082
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk